About this Journal Submit a Manuscript Table of Contents
BioMed Research International
Volume 2014 (2014), Article ID 261631, 8 pages
http://dx.doi.org/10.1155/2014/261631
Research Article

Construction of a Novel Liver-Targeting Fusion Interferon by Incorporation of a Plasmodium Region I-Plus Peptide

1Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances, Guangdong Pharmaceutical University, 280 Wai Huan Dong Road, Guangzhou Higher Education Mega Center, Guangzhou 510006, China
2School of Basic Courses, Guangdong Pharmaceutical University, 280 Wai Huan Dong Road, Guangzhou Higher Education Mega Center, Guangzhou 510006, China

Received 1 August 2013; Accepted 12 September 2013; Published 19 January 2014

Academic Editor: Thomas Minor

Copyright © 2014 Xuemei Lu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Ceaglio, M. Etcheverrigaray, H. S. Conradt, N. Grammel, R. Kratje, and M. Oggero, “Highly glycosylated human alpha interferon: an insight into a new therapeutic candidate,” Journal of Biotechnology, vol. 146, no. 1-2, pp. 74–83, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Belloni, L. Allweiss, F. Guerrieri et al., “IFN-α inhibits HBV transcription and replication in cell culture and in humanized mice by targeting the epigenetic regulation of the nuclear cccDNA minichromosome,” The Journal of Clinical Investigation, vol. 122, no. 2, pp. 529–537, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. D. S. Retnoningrum, R. A. Ningrum, Y. N. Kurniawan, A. Indrayati, and H. Rachmawati, “Construction of synthetic open reading frame encoding human interferon alpha 2b for high expression in Escherichia coli and characterization of its gene product,” Journal of Biotechnology, vol. 145, no. 2, pp. 193–198, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. Y. Suginoshita, Y. Tabata, F. Moriyasu, Y. Ikada, and T. Chiba, “Liver targeting of interferon-β with a liver-affinity polysaccharide based on metal coordination in mice,” The Journal of Pharmacology and Experimental Therapeutics, vol. 298, no. 2, pp. 805–811, 2001. View at Scopus
  5. R. Iorio, P. Pensati, S. Botta et al., “Side effects of alpha-interferon theraphy and impact on health-related quality of life in children with chronic viral hepatitis,” The Pediatric Infectious Disease Journal, vol. 16, no. 10, pp. 984–990, 1997. View at Publisher · View at Google Scholar · View at Scopus
  6. M. K. Yoo, I. Y. Kim, E. M. Kim et al., “Superparamagnetic iron oxide nanoparticles coated with galactose-carrying polymer for hepatocyte targeting,” Journal of Biomedicine and Biotechnology, vol. 2007, Article ID 94740, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. P. C. N. Rensen, R. L. A. De Vrueh, and T. J. C. van Berkel, “Targeting hepatitis B therapy to the liver. Clinical pharmacokinetic considerations,” Clinical Pharmacokinetics, vol. 31, no. 2, pp. 131–155, 1996. View at Scopus
  8. L. Fiume, G. Di Stefano, C. Busi et al., “Liver targeting of antiviral nucleoside analogues through the asialoglycoprotein receptor,” Journal of Viral Hepatitis, vol. 4, no. 6, pp. 363–370, 1997. View at Scopus
  9. R. Tewari, R. Spaccapelo, F. Bistoni, A. A. Holder, and A. Crisanti, “Function of region I and II adhesive motifs of Plasmodium falciparum circumsporozoite protein in sporozoite motility and infectivity,” The Journal of Biological Chemistry, vol. 277, no. 49, pp. 47613–47618, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. M. M. Mota and A. Rodriguez, “Invasion of mammalian host cells by Plasmodium sporozoites,” BioEssays, vol. 24, no. 2, pp. 149–156, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Rathore, R. Nagarkatti, D. Jani et al., “An immunologically cryptic epitope of Plasmodium falciparum circumsporozoite protein facilitates liver cell recognition and induces protective antibodies that block liver cell invasion,” The Journal of Biological Chemistry, vol. 280, no. 21, pp. 20524–20529, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. A. P. Singh, C. A. Buscaglia, Q. Wang et al., “Plasmodium Circumsporozoite Protein Promotes the Development of the Liver Stages of the Parasite,” Cell, vol. 131, no. 3, pp. 492–504, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. M. Prudêncio, A. Rodriguez, and M. M. Mota, “The silent path to thousands of merozoites: the Plasmodium liver stage,” Nature Reviews Microbiology, vol. 4, no. 11, pp. 849–856, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. J. B. Ancsin and R. Kisilevsky, “A binding site for highly sulfated heparan sulfate is identified in the N terminus of the circumsporozoite protein: significance for malarial sporozoite attachment to hepatocytes,” The Journal of Biological Chemistry, vol. 279, no. 21, pp. 21824–21832, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. L. Young and Q. Dong, “Two-step total gene synthesis method,” Nucleic Acids Research, vol. 32, no. 7, p. e59, 2004. View at Scopus
  16. G. Huang, Q. Wen, Q. Gao, F. Zhang, and Y. Bai, “An efficient and rapid method for cDNA cloning from difficult templates using codon optimization and SOE-PCR: with human RANK and TIMP2 gene as examples,” Biotechnology Letters, vol. 33, no. 10, pp. 1939–1947, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Sahdev, S. Saini, P. Tiwari, S. Saxena, and K. Singh Saini, “Amplification of GC-rich genes by following a combination strategy of primer design, enhancers and modified PCR cycle conditions,” Molecular and Cellular Probes, vol. 21, no. 4, pp. 303–307, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Shen, X.-M. Lu, X.-B. Jin et al., “Expression of a novel dual-functional protein—the antimicrobial peptide LL-37 fused with human acidic fibroblast growth factor in Escherichia coli,” Protein Expression and Purification, vol. 81, no. 1, pp. 119–125, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. X.-M. Lu, X.-B. Jin, J.-Y. Zhu et al., “Expression of the antimicrobial peptide cecropin fused with human lysozyme in Escherichia coli,” Applied Microbiology and Biotechnology, vol. 87, no. 6, pp. 2169–2176, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. S. Salunkhe, B. Prasad, K. Sabnis-Prasad, A. Apte-Deshpande, and S. Padmanabhan, “Expression and purification of SAK-fused human interferon alpha in Escherichia coli,” Journal of Microbial & Biochemical Technology, vol. 1, no. 1, pp. 5–10, 2009.
  21. D. S. Retnoningrum, R. A. Ningrum, Y. N. Kurniawan, A. Indrayati, and H. Rachmawati, “Construction of synthetic open reading frame encoding human interferon alpha 2b for high expression in Escherichia coli and characterization of its gene product,” Journal of Biotechnology, vol. 145, no. 2, pp. 193–198, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. C. A. Valente, D. M. F. Prazeres, J. M. S. Cabral, and G. A. Monteiro, “Translational features of human alpha 2b interferon production in Escherichia coli,” Applied and Environmental Microbiology, vol. 70, no. 8, pp. 5033–5036, 2004. View at Publisher · View at Google Scholar · View at Scopus
  23. I. Rabhi-Essafi, A. Sadok, N. Khalaf, and D. M. Fathallah, “A strategy for high-level expression of soluble and functional human interferon α as a GST-fusion protein in E.coli,” Protein Engineering, Design and Selection, vol. 20, no. 5, pp. 201–209, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. F. O. Neves, P. L. Ho, I. Raw, C. A. Pereira, C. Moreira, and A. L. T. O. Nascimento, “Overexpression of a synthetic gene encoding human alpha interferon in Escherichia coli,” Protein Expression and Purification, vol. 35, no. 2, pp. 353–359, 2004. View at Publisher · View at Google Scholar · View at Scopus